Michel Galiay currently serves as the Président of the Transitions Management Think Tank, where he leverages his extensive experience in the pharmaceutical sector to foster innovative management practices that prioritize human-centric and sustainable approaches. With a robust background in overseeing pharmaceutical operations, Michel has effectively...
Michel Galiay currently serves as the Président of the Transitions Management Think Tank, where he leverages his extensive experience in the pharmaceutical sector to foster innovative management practices that prioritize human-centric and sustainable approaches. With a robust background in overseeing pharmaceutical operations, Michel has effectively managed a site with 60 employees at Bertin Pharma, where he was instrumental in merging two entities and spearheading site expansion initiatives. His expertise in multisite operational management has allowed him to optimize processes and enhance productivity across various locations.
At Novexel, Michel played a pivotal role in strategic meetings and the management of a non-GMP discovery laboratory, where he directly oversaw subcontractors across multiple countries, including India, Italy, Sweden, and the Netherlands. His ability to create and implement comprehensive development plans has been crucial in driving projects forward and ensuring compliance with regulatory standards in drug development and clinical trials.
As the leader of the Transitions Management Think Tank, Michel is committed to promoting a forward-thinking approach to management that integrates best practices in regulatory affairs, technology transfer, and R&D. His vision is to cultivate a collaborative environment where pharmaceutical leaders can share insights and strategies for navigating the complexities of the industry. Michel's dedication to fostering a culture of leadership and innovation positions him as a key influencer in shaping the future of pharmaceutical management, ensuring that organizations not only thrive but also contribute positively to the healthcare ecosystem.
